Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turoctocog alfa in previously untreated pediatric patients with hemophilia A
CTR20150455Phase 3Active
- Sponsor
- Novo Nordisk
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Jul 2015; status: active.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20150455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150455.